Clinical Trial Update: Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty [Phase 2]

View source ↗

Summary

Phase II clinical study of H001 Capsule to prevent venous thromboembolism after total knee arthroplasty is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• H001 Capsule

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Circulatory Disease | Phase 2 | Status: RECRUITING